ERK1/2 Signaling Pathway in the Release of VEGF from Müller Cells in Diabetes
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
PURPOSE: Diabetic retinopathy (DR) is one of the most serious complications of diabetes and has become a major blinding eye disease, but its treatment remains unsatisfactory. The ERK1/2 signaling pathway has been shown to participate in regulating secretion of VEGF in DR from our previous studies. The role of VEGF in the development of DR provides a target for treatment. Our present research focuses on Müller cells, a major source of VEGF secretion, to investigate the role of ERK1/2 signaling pathway on regulation of VEGF release in diabetes. METHODS: Immunofluorescence was used to observe the ERK1/2 phosphorylation activity on early diabetic rat retinal Müller cells. Müller cells were stimulated by high glucose in vitro. Western blot and immunohistochemistry were used to determine ERK1/2 signaling pathway expression and phosphorylation. AP-1 DNA binding activity status was monitored by electrophoretic mobility shift assay (EMSA). ELISA and PCR monitored VEGF secretion. Inhibition of ERK1/2 phosphorylation with U0126 was observed for changes in VEGF secretion. RESULTS: Phos-ERK1/2 was expressed on Müller cells early in diabetes. In vitro high glucose stimulation of Müller cells increased VEGF secretion with a peak at 24 hours. An ERK1/2 specific inhibitor, U0126, stopped the phosphorylation of ERK1/2, lowered AP-1 DNA binding activity, and reduced Müller cells secretion of VEGF under high glucose conditions. CONCLUSIONS: ERK1/2 signaling pathway has some role in regulating Müller cells secretion of VEGF in DR. Targeting the ERK1/2 signaling pathway in Müller cells through intervention of the upstream signaling pathway or nuclear transcription factors of VEGF secretion could be a type of anti-VEGF treatment for DR.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and that it specifically regulates VEGF secretion by MG cells [ 81 ].”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [81]
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Karin, M., Liu, Z.-G., & Zandi, E. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80068-3 · Cited by 2,893
The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases
Karin, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16483 · Cited by 2,431
Signal Transduction through MAP Kinase Cascades
(1998) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60765-4 · Cited by 1,759
Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., & Abraham, J. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99049-6 · Cited by 1,476
Pierce, E. A., Avery, R. L., Foley, E. D., Aiello, L. P., & Smith, L. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.905 · Cited by 1,027
Stone, J., Itin, A., Alon, T., Pe'er, J., Gnessin, H., Chan-Ling, T., & Keshet, E. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-07-04738.1995 · Cited by 1,006
The Müller cell: a functional element of the retina
Newman, E., & Reichenbach, A. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10040-0 · Cited by 788
Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy.
Mizutani, M., Kern, T. S., & Lorenzi, M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118746 · Cited by 706
Activation of ternary complex factor Elk-1 by MAP kinases.
Janknecht, R., Ernst, W. H., Pingoud, V., & Nordheim, A. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06204.x · Cited by 560
Cited by
Impact of the opioid system on the reproductive axis
Böttcher, B., Seeber, B., Leyendecker, G., & Wildt, L. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.06.009 · Cited by 115
Small-molecule compounds target paraptosis to improve cancer therapy
Wang, Y., Wen, X., Zhang, N., Wang, L., Hao, D., Jiang, X. L., & He, G. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109203 · Cited by 91
Long, L., Li, Y., Yu, S., Li, X., Hu, Y., Long, T., Wang, L., Li, W., Ye, X., Ke, Z., et al. (2019) · Journal of Diabetes Research · doi:10.1155/2019/4875421 · Cited by 73
Self-citationLi, T., Hu, J., Du, S., Chen, Y., Wang, S., & Wu, Q. E. (2014) · PubMed Central · Cited by 73
Fan, Y., Liu, K., Wang, Q., Ruan, Y., Ye, W., & Zhang, Y. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.05.004 · Cited by 70
MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges
Moustardas, P., Aberdam, D., & Lagali, N. (2023) · Cells · doi:10.3390/cells12040617 · Cited by 63
“Other in vivo studies have also concluded that the ERK1/2 signaling pathway is involved in VEGF release in the diabetic rat retina [80], and that it specifically regulates VEGF secretion by MG cells [81].”
BackgroundMelatonin-Mediated Cytoprotection against Hyperglycemic Injury in Müller Cells
Jiang, T., Chang, Q., Zhao, Z., Yan, S., Wang, L., Cai, J., & Xu, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050661 · Cited by 48
“Cells at passages 2 to 4 were used for experiments [21].”
MethodSelf-citationActivation of retinal Müller cells in response to glucose variability
Picconi, F., Parravano, M., Sciarretta, F., Fulci, C., Nali, M., Frontoni, S., Varano, M., & Caccuri, A. M. (2019) · Endocrine · doi:10.1007/s12020-019-02017-5 · Cited by 49
Involvement of P2X 7 receptors in retinal ganglion cell apoptosis induced by activated Müller cells
Xue, B., Xie, Y., Xue, Y., Hu, N., Zhang, G., Guan, H., & Ji, M. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2016.10.005 · Cited by 47
Matteucci, A., Gaddini, L., Villa, M., Varano, M., Parravano, M., Monteleone, V., Cavallo, F., Leo, L., Mallozzi, C., Malchiodi‐Albedi, F., et al. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.05.011 · Cited by 48
“Furthermore, very early in diabetes, pERK1/2 has been immunolocalized in Müller glia (Ye et al., 2012).”
BackgroundTang, W., Ma, J., Gu, R., Ding, X., Lei, B., Wang, X., Zhuang, H., & Xu, G. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000488472 · Cited by 46
Self-citationHu, J., Wu, Q. E., Li, T., Chen, Y., & Wang, S. (2013) · Experimental Eye Research · doi:10.1016/j.exer.2013.01.011 · Cited by 47
Niu, W., Liu, X., Deng, B., Hong, T., Wang, C., Yan, Y., Liu, J., Jiang, Y., & Li, J. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02625-8 · Cited by 47
“ERK1/2 is a member of the mitogen active protease (MAPK) family, which promotes cell division and proliferation [52].”
Xie, J., Cui, Y., Chen, X., Yu, H., Chen, J., Huang, T., He, M., Zhang, L., & Meng, Q. (2021) · Experimental Eye Research · doi:10.1016/j.exer.2021.108640 · Cited by 37
Wu, X., Pu, L., Chen, W., Zhao, Q., Wu, G., Li, D., & Zhu, H. (2022) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2022.2055565 · Cited by 30
Transcription factors regulate GPR91-mediated expression of VEGF in hypoxia-induced retinopathy
Li, T., Hu, J., Gao, F., Du, X., Chen, Y., & Wu, Q. E. (2017) · Scientific Reports · doi:10.1038/srep45807 · Cited by 26
Primary Retinal Cultures as a Tool for Modeling Diabetic Retinopathy: An Overview
Matteucci, A., Varano, M., Mallozzi, C., Gaddini, L., Villa, M., Gabrielli, S., Formisano, G., Pricci, F., & Malchiodi‐Albedi, F. (2015) · BioMed Research International · doi:10.1155/2015/364924 · Cited by 29
“Targeting ERK1/2 signaling pathway with U0126, an ERK1/2 specific inhibitor, able to reduce VEGF secretion in Müller cells, could be investigated as anti-VEGF treatment for DR [184].”
BackgroundLi, Y., Alhendi, A. M. N., Yeh, M.-C., Elahy, M., Santiago, F. S., Deshpande, N., Wu, B. J., Chan, E., Inam, S., Prado-Lourenço, L., et al. (2020) · Science Advances · doi:10.1126/sciadv.aaz7815 · Cited by 26
“BT2 inhibited ERK activation and VCAM-1 expression, both implicated in the pathogenesis of nAMD and DR ( 14 , 15 , 48 , 49 ).”
Gene Expression Changes under Cyclic Mechanical Stretching in Rat Retinal Glial (Müller) Cells
Wang, X., Fan, J., Zhang, M., Sun, Z., & Xu, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063467 · Cited by 25
“Confluent cultures were passaged no more than four times, and cultures with the same number of passages were used for each independent experiment [35].”
MethodSelf-citationSeeber, B., Böttcher, B., D’Costa, E., & Wildt, L. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2019.07.001 · Cited by 26
Liu, Y., Wang, C., & Su, G. (2019) · Journal of Ophthalmology · doi:10.1155/2019/5743109 · Cited by 26
“*e ERK1/2 signaling pathway is required for Müller cells in early stage diabetes and primary Müller cells in vitro under the condition of high-glucose stimulation [176].”
BackgroundThe role of ERK1/2 signaling in diabetes: pathogenic and therapeutic implications
Xu, H., Liu, T., Dai, Y., Li, N., & Cao, Z. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1600251 · Cited by 22
“It was found that the ERK1/ 2 signaling pathway plays a key role in diabetes and its complications, and its activation is associated with a variety of pathological processes (Ye et al., 2012; Xu et al., 2016; Ajay et al., 2024).”
Mammone, T., Chidlow, G., Casson, R. J., & Wood, J. P. M. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.01.002 · Cited by 18
“…retinal ischemia (Roth et al., 2003; Kim et al., 2016) optic nerve transection (Nakazawa et al., 2002; Nitzan et al., 2006; Kikuchi et al., 2000), experimentally-elevated IOP (Dapper et al., 2013), endotoxininduced uveitis (Takeda and Ichijo, 2002) and experimental diabetes (Ye et al., 2012).”
BackgroundReichenbach, A., & Bringmann, A. (2015) · Colloquium Series on Neuroglia in Biology and Medicine From Physiology to Disease · doi:10.4199/c00122ed1v01y201412ngl003 · Cited by 20
Grigsby, J. G., Allen, D., Ferrigno, A. S., Vellanki, S., Pouw, C. E., Hejny, W., & Tsin, A. T. C. (2016) · Current Diabetes Reviews · doi:10.2174/1573399812666161007165944 · Cited by 23
Ye, X., Ren, H., Jiang, T., Zhang, T., & Li, G. (2020) · Cytotechnology · doi:10.1007/s10616-020-00379-7 · Cited by 16
Self-citationSenthilkumari, S., Rajendran, S., Chidambaranathan, G., & Vanniarajan, A. (2016) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2016.0103 · Cited by 18
Ma, M., Du, Q., Shi, S., Lv, J., Zhang, W., Ge, D., Xing, L., & Yu, N. (2024) · Molecules · doi:10.3390/molecules29133019 · Cited by 14
“Among the active compounds, Paeoniflorin, Albiflorin, Paeonin C, Paeonidaninol A, Naringenin-7-O -glucoside, (+)-Paeonilactone C, Guaiphenesin, 5-Hydroxyisovanillic acid, Gallic acid, and Benzoic acid interact with 57, 49, 47, 45, 43, 32, 22, 8, 7, and 5 targets, respectively.”
BackgroundLiu, T., Hao, Q., Zhang, Y., Li, Z., Cui, Z., & Yang, W. (2018) · Acta Ophthalmologica · doi:10.1111/aos.13715 · Cited by 13
“Through regulating secretion of VEGF, the ERK1/2 signalling pathway contributes to the DR (Ye et al. 2012).”
BackgroundHigh Glucose and Glucose Deprivation Modulate Müller Cell Viability and VEGF Secretion
Vellanki, S., Ferrigno, A. S., Escuela de Medicina, T. D. M., Alanis, Y., Betts-Obregon, B. S., & Tsin, A. C. (2016) · International Journal of Ophthalmology & Eye Science · doi:10.19070/2332-290x-1600037 · Cited by 13
“Previous studies suggest that elevated levels of VEGF in Müller cells in various glucose conditions may be related to intracellular calcium, hypoxia inducible factor, ERK 1⁄2 pathway and others [33, 36, 39].”
BackgroundMüller glia activation by VEGF-antagonizing drugs: An in vitro study on rat primary retinal cultures
Gaddini, L., Varano, M., Matteucci, A., Mallozzi, C., Villa, M., Pricci, F., & Malchiodi‐Albedi, F. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.11.010 · Cited by 12
Peña, J. S., & Vázquez, M. (2020) · Brain Sciences · doi:10.3390/brainsci10060330 · Cited by 12
“Recent reports have also established the relationship between downstream extracellular signal-regulated kinase 1 and 2 (ERK1/2) signaling on elevated VEGF concentration in MG in diabetic retina [67,68].”
BackgroundOpiate receptor blockade on human granulosa cells inhibits VEGF release
Lunger, F., Vehmas, A. P., Fürnrohr, B. G., Sopper, S., Wildt, L., & Seeber, B. (2016) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2015.12.006 · Cited by 11
“Experimental evidence shows that endogenous opioids stimulate angiogenesis in other cells, such as retinal epithelial cells and dermal microvascular endothelial cells, through a stimulatory effect on VEGF production and that this effect can be attenuated by inhibiting the ERK1/2 signalling pathway or by administering…”
BackgroundMethodDai, X., Yang, J., Ye, Y., Wang, C., Liu, Y., Zhang, M., Chai, X., Wen, X., & Wang, Y. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119873 · Cited by 10
Self-citationCai, C., Tahiri, H., Fortin, C. F., Ortiz, C., Sintjago, H., Yang, C., & Hardy, P. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112470 · Cited by 10
Ogata, T., Ashimori, A., Higashijima, F., Sakuma, A., Hamada, W., Sunada, J., Aoki, R., Mikuni, M., Hayashi, K., Yoshimoto, T., et al. (2024) · Experimental Eye Research · doi:10.1016/j.exer.2024.110051 · Cited by 9
Retinopathy of prematurity shows alterations in Vegfa164 isoform expression
Mezu‐Ndubuisi, O. J., Song, Y., Macke, E. L., Johnson, H., Nwaba, G., Ikeda, A., & Sheibani, N. (2021) · Pediatric Research · doi:10.1038/s41390-021-01646-9 · Cited by 8
Wang, S., Wang, X., Chen, J., Wang, M., & Zhang, C. (2024) · Aging · doi:10.18632/aging.205870 · Cited by 10
“In diabetic patients, elevated blood glucose and AGEs levels inhibit the normal function of the VEGF signaling pathway [20, 21].”
BackgroundHosseinpoor, Z., Soheili, Z., Davari, M., Latifi‐Navid, H., Samiee, S., & Samiee, D. (2024) · PLoS ONE · doi:10.1371/journal.pone.0310999 · Cited by 4
(2022) · PubMed · doi:10.14670/hh-18-427 · Cited by 4
Self-citationLiu, X., Song, Y., Tian, W., Ye, L., Li, D., Li, M., Tian, X., & Li, X. (2025) · Growth Factors · doi:10.1080/08977194.2025.2533773 · Cited by 1
“Specifically, in Müller cells, VEGF has been shown to promote the activation of the ERK1/2 pathway, contributing to the development of diabetic retinopathy (Ye et al. 2012).”
Aldarwesh, A. (2015) · UEA Digital Repository (University of East Anglia) · Cited by 2
Singla, S., Jyoti, U., Singh, T., & Devi, S. (2026) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2026.2638751
“Similarly, in diabetic retinopathy, ERK1/2-mediated VEGF overexpression contributes to vascular leakage and neovascularization [53], while in diabetic neuropathy, ERK1/2 activation in Schwann cells leads to demyelination and neuroinflammation [54].”
Therapeutic potential of mesenchymal stem cell-derived exosome on the retinopathy of prematurity
Namakin, K., Mostafaei, M., Tanourlouee, S. B., Dolikhani, M., Boroujerdi, T., Araghi, A. S., Masoumi, A., & Zolbin, M. M. (2026) · Experimental Eye Research · doi:10.1016/j.exer.2026.111067
Metadata
- Authors
- Ye, X., Ren, H., Zhang, M., Sun, Z., Jiang, A. C., & Xu, G.
- Affiliations
- Shanghai Medical College of Fudan University (CN)
- Corresponding author
- Ye, Xiaofeng
- Ren, Hui
- Zhang, Meng
- Sun, Zhongcui
- Jiang, Alice C.
- Xu, Gezhi
- Venue
- Investigative Opthalmology & Visual Science
- Published
- 2012-06-08
- Volume
- 53
- Issue
- 7
- Pages
- 3481
- ISSN
- 0146-0404 (ISSN-L)
- 1552-5783
- OpenAlex
- W1963818413
- Cited by
- 44
- References
- 43
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 4 · 2023: 1 · 2022: 2 · 2021: 3 · 2020: 3 · 2019: 5 · 2018: 3 · 2017: 2 · 2016: 5 · 2015: 4 · 2014: 3 · 2013: 2 · 2012: 1
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Investigative Ophthalmology & Visual Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Keywords
- ERK signaling, VEGF secretion, Müller cells, diabetic retinopathy, high glucose, AP-1 DNA binding, U0126, ERK1/2 phosphorylation, anti-VEGF therapy
- MeSH terms
- Animals, Butadienes, Diabetes Mellitus, Experimental, Diabetic Retinopathy, Enzyme Inhibitors, Enzyme-Linked Immunosorbent Assay, Glucose, Male, Neuroglia, Nitriles, Phosphorylation, Blotting, Western, Rats, Sprague-Dawley, Transcription Factor AP-1, Fluorescent Antibody Technique, Indirect, Mitogen-Activated Protein Kinase 1, MAP Kinase Signaling System, Electrophoretic Mobility Shift Assay, Vascular Endothelial Growth Factor A, Mitogen-Activated Protein Kinase 3, Rats, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.